Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, today announced that it has been certified compliant with ISO/IEC 27001:2005, an international information security management standard. Extending to all data generation and security procedures, including OGT's CytoSureTM and GenefficiencyTM services, biomarker discovery solutions, and the development of CytoSure Interpret Software, this certification acknowledges that data confidentiality, availability and integrity is carefully managed and controlled.
Building on the ISO 9001:2008 registration earlier this year, OGT's new ISO/IEC 27001:2005 certification provides clear evidence of robust information security to meet all customer needs. Dr Mike Evans, OGT's CEO, commented: "Being one of only 448 companies within the UK to be compliant with ISO/IEC 27001:2005 demonstrates our ongoing commitment to information security and confidentiality. It also emphasises the dedication and reliability of our team to provide high-quality products and services, while protecting the integrity and confidentiality of all information and data."
The ISO/IEC 27001:2005 certification was awarded following an assessment by the British Standards Institution (BSI).
For further information on OGT's products and services, please visit www.ogt.co.uk
Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, today announced that it has been certified compliant with ISO/IEC 27001:2005, an international information security management standard. Extending to all data generation and security procedures, including OGT's CytoSureTM and GenefficiencyTM services, biomarker discovery solutions, and the development of CytoSure Interpret Software, this certification acknowledges that data confidentiality, availability and integrity is carefully managed and controlled.